Xenetic BiosciencesXBIO
13F holders, Q2 2025 (June 30)9holders −4
0new positions
4sold out
1famous investor
$3.90avg. 13F price*
At the end of Q2 2025, 9 institutions reported holding Xenetic Biosciences Inc. (XBIO) in their 13F filings, down 4 from Q1 2025. 0 opened new positions and 4 sold out. The largest holders were Renaissance Technologies ($97K), Sachetta, LLC ($60K) and LGT Group Foundation ($41K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Xenetic Biosciences Inc.
- CUSIP
- 984015602
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $119K |
All 13F filers, Q1 2025 → Q2 2025: 4,595 shares bought and 47,921 shares sold, net −43,326 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Renaissance Technologies | 0.00% | Reduce -7.5% | 24,750 | $97K |
| Sachetta, LLC | 0.02% | Add +43.1% | 15,259 | $60K |
| LGT Group Foundation | 0.00% | No change | 11,000 | $41K |
| Geode Capital Management, LLC | 0.00% | Reduce -4.3% | 10,478 | $41K |
| JTC Employer Solutions Trustee Ltd | 0.00% | No change | 2,700 | $11K |
| Bank of America Corp. | 0.00% | Add +18.2% | 13 | $51 |
| SBI Securities Co., Ltd. | 0.00% | No change | 5 | $20 |
| Morgan Stanley | 0.00% | No change | 4 | $16 |
| Darwin Wealth Management, LLC | 0.00% | No change | 2 | $7 |
"% of holder's portfolio" is XBIO's weight in each manager's 13F, not the share of Xenetic Biosciences Inc. the manager owns.